Affinage

P2RX6

P2X purinoceptor 6 · UniProt O15547

Length
441 aa
Mass
48.8 kDa
Annotated
2026-04-29
21 papers in source corpus 13 papers cited in narrative 13 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

P2RX6 encodes an ATP-gated cation channel subunit that cannot form functional homomeric receptors due to an inhibitory uncharged N-terminal domain that prevents oligomerization and retains monomeric P2X6 in the endoplasmic reticulum (PMID:15657042, PMID:16452399). P2X6 instead assembles into heteromeric channels with P2X2 and/or P2X4 subunits—including P2X2/6, P2X4/6, and P2X2/4/6 heterotrimers—that traffic to the cell surface and exhibit distinct pharmacological properties such as altered agonist potencies, α,β-methylene-ATP sensitivity, and suramin blockade profiles (PMID:9736638, PMID:10864944, PMID:24815693). N-linked glycosylation regulates P2X6 surface expression and channel function, and the subunit undergoes age-dependent nuclear translocation in hippocampal neurons where it interacts with splicing factor 3A1 to reduce mRNA splicing activity (PMID:15044628, PMID:25874565). P2X6 is a p53-inducible gene, and in renal cell carcinoma, ATP-activated P2RX6 mediates Ca²⁺ influx that drives ERK1/2 phosphorylation and MMP9-dependent invasion (PMID:9242461, PMID:31159832).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 1996 High

    Cloning of P2X6 established it as a member of the P2X ATP-gated ion channel family but revealed unusually low expression, raising the question of whether it forms functional homomeric channels.

    Evidence cDNA cloning and heterologous expression with electrophysiology

    PMID:8786426

    Open questions at the time
    • No evidence for homomeric channel function at physiological expression levels
    • Subunit stoichiometry unknown
    • Tissue-specific role not addressed
  2. 1997 Medium

    Identification of P2RX6 as a p53-inducible gene with functional p53-binding sites linked it to stress-responsive transcriptional programs, beyond its role as an ion channel subunit.

    Evidence p53-tagged genomic cloning, Northern blot, chromosomal mapping

    PMID:9242461

    Open questions at the time
    • Functional consequence of p53-mediated P2X6 induction not tested
    • No demonstration that p53 regulation affects channel activity or cell fate
  3. 1998 High

    Demonstration that P2X6 coassembles with P2X4 into heteromeric receptors with novel pharmacology resolved the question of how P2X6 contributes to purinergic signaling despite its inability to form surface homomers.

    Evidence Xenopus oocyte electrophysiology and epitope-tag co-immunoprecipitation in HEK-293 cells

    PMID:9736638

    Open questions at the time
    • Subunit stoichiometry within the heteromer not determined
    • Native tissue relevance not confirmed
  4. 2000 High

    Reconstitution of P2X2/6 heteromers showed that P2X6 modifies P2X2 pharmacology including agonist potency, pH sensitivity, and antagonist profile, establishing P2X6 as a modifier subunit rather than an autonomous channel.

    Evidence Voltage-clamp electrophysiology in Xenopus oocytes

    PMID:10864944

    Open questions at the time
    • Relative contribution of each subunit to the pore and gating unknown
    • No structural data on the heteromeric complex
  5. 2004 High

    Discovery that N-linked glycosylation controls P2X6 receptor functionality connected post-translational processing to the variable functional outcomes observed across expression systems.

    Evidence Western blot with N-glycosidase F treatment and electrophysiology

    PMID:15044628

    Open questions at the time
    • Specific glycosylation sites responsible not identified
    • Mechanism linking glycosylation state to channel gating unknown
  6. 2005 High

    Chemical cross-linking and AFM imaging proved that P2X6 exists as a monomer, unlike P2X2 which forms trimers, providing the biophysical basis for its obligate heteromeric assembly.

    Evidence Chemical cross-linking and atomic force microscopy

    PMID:15657042

    Open questions at the time
    • Structural determinants preventing homomeric assembly beyond the N-terminus not identified
  7. 2006 High

    Mutagenesis of a 14-residue uncharged N-terminal region revealed the molecular mechanism of P2X6 ER retention: removing this region permits homotrimer formation and surface trafficking, though the homotrimers remain non-functional as channels.

    Evidence Surface biotinylation, immunocytochemistry, AFM, and targeted mutagenesis

    PMID:16452399

    Open questions at the time
    • Why surface-expressed P2X6 homotrimers lack channel function remains unexplained
    • Whether this N-terminal motif acts via chaperone recognition or intrinsic folding is unclear
  8. 2014 High

    Sequential co-IP and AFM antibody decoration demonstrated that P2X2, P2X4, and P2X6 form a heterotrimeric complex containing one of each subunit, expanding the combinatorial diversity of purinergic receptors.

    Evidence Sequential co-immunoprecipitation and AFM with antibody decoration in tsA 201 cells

    PMID:24815693

    Open questions at the time
    • Functional properties of the P2X2/4/6 heterotrimer not characterized electrophysiologically
    • Native tissue occurrence not confirmed
  9. 2015 Medium

    Age-dependent nuclear accumulation of P2X6 in hippocampal neurons and its interaction with splicing factor 3A1 revealed an unexpected non-channel function: regulation of mRNA splicing, linking P2X6 to age-related transcriptome changes.

    Evidence Immunofluorescence, nuclear fractionation, co-immunoprecipitation, and splicing activity assays in hippocampal neurons

    PMID:25874565

    Open questions at the time
    • Mechanism of nuclear translocation from the ER not fully resolved
    • Specific mRNA targets whose splicing is affected not identified
    • Single-lab finding awaits independent confirmation
  10. 2019 Medium

    In renal cell carcinoma, ATP-activated P2RX6 drives Ca²⁺ influx leading to ERK1/2 phosphorylation and MMP9-dependent invasion, placing P2X6 in a pro-metastatic signaling axis that is suppressed by METTL14-mediated m⁶A modification of P2RX6 mRNA.

    Evidence In vitro migration/invasion assays, Ca²⁺ imaging, Western blot, METTL14 knockdown/overexpression, in vivo xenograft

    PMID:31159832

    Open questions at the time
    • Whether P2X6 acts as a homomer or heteromer in RCC cells not determined
    • Generalizability to other cancer types unknown
    • Single-lab finding

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the structural basis for why P2X6 homotrimers are non-functional as channels, the identity of mRNA targets affected by nuclear P2X6–SF3A1 interaction, and whether the P2X2/4/6 heterotrimer exists and functions in native tissues.
  • No high-resolution structure of P2X6-containing heteromers
  • Nuclear P2X6 function not validated in vivo beyond a single lab
  • Native tissue stoichiometry and subunit composition of P2X6 heteromers undetermined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 4
Localization
GO:0005886 plasma membrane 3 GO:0005634 nucleus 1 GO:0005783 endoplasmic reticulum 1
Pathway
R-HSA-382551 Transport of small molecules 4 R-HSA-162582 Signal Transduction 1
Partners
P2RX2P2RX4SF3A1SPTAN1
Complex memberships
P2X2/4/6 heterotrimerP2X2/6 heteromerP2X4/6 heteromer

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1996 P2X6 receptor subunits were cloned and expressed; they form ATP-gated ion channels with two transmembrane segments and a large extracellular loop, desensitize slowly, do not respond to alpha-beta-methylene-ATP, and are not blocked by suramin or PPADS. P2X6 expresses at lower levels than other P2X subunits, suggesting it does not normally form homomultimeric channels. cDNA cloning, heterologous expression, electrophysiology The Journal of neuroscience High 8786426
1998 P2X4 and P2X6 subunits coassemble into a novel heteromeric ATP receptor with unique pharmacological properties: activated by low-micromolar alpha-beta-methylene ATP (EC50=12 µM) and blocked by suramin and Reactive Blue 2. Heteromeric assembly was demonstrated by specific copurification of epitope-tagged subunits from HEK-293 cells. P2X6 alone does not assemble into surface receptors in Xenopus oocytes. Xenopus oocyte expression, electrophysiology, co-immunoprecipitation/copurification with epitope tags in HEK-293 cells The Journal of neuroscience High 9736638
2000 Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes generates a heteromeric rP2X2/6 receptor with distinct pharmacology from homomeric P2X2: reduced agonist potencies, loss of some agonist activity, biphasic ATP-evoked currents, altered pH modulation, and changed suramin blockade profile. Xenopus oocyte expression, voltage-clamp electrophysiology The Journal of neuroscience High 10864944
2005 P2X6 receptor subunits do not oligomerize into stable homomers. Chemical cross-linking of P2X6 did not produce higher-order adducts, and AFM imaging showed a mean molecular volume (~145 nm³) consistent with monomers, in contrast to P2X2 which forms trimers (~409 nm³). Chemical cross-linking, atomic force microscopy (AFM) imaging The Journal of biological chemistry High 15657042
2004 N-linked glycosylation regulates P2X6 receptor function. Functional P2X6 receptors show increased glycosylation (~70 kDa) compared to non-functional receptors (~60 kDa); N-glycosidase F treatment collapses both to ~55 kDa. Functional P2X6 displays a novel phenotype sensitive to alpha-beta-methylene ATP (EC50=0.6 µM), slow desensitization, and resistance to suramin. Western blot, N-glycosidase F treatment, electrophysiology, RT-PCR Molecular pharmacology High 15044628
2006 An uncharged 14-amino acid region at the N-terminus of P2X6 inhibits its assembly and ER export. When this region is removed or charged residues are added, P2X6 forms homotrimers, undergoes complex glycosylation, and traffics to the plasma membrane, but remains non-functional. As a heteromer with P2X2 or P2X4, P2X6 exits the ER and is expressed at the cell surface or constitutively internalized depending on partner subunit. Immunocytochemistry, surface biotinylation, atomic force microscopy, targeted mutagenesis Molecular pharmacology High 16452399
2002 P2X6 receptors co-localize with VE-cadherin at cell-cell junctions in human umbilical vein endothelial cells and are rapidly internalized upon reduction of extracellular Ca2+. Unlike P2X4, P2X6 could not be co-immunoprecipitated with VE-cadherin, indicating distinct association modes at adherens junctions. Confocal microscopy, electron microscopy, co-immunoprecipitation, Triton X-100 fractionation Cellular and molecular life sciences Medium 12088286
2014 P2X2, P2X4, and P2X6 subunits can form a heterotrimeric complex containing all three distinct subunits. Sequential co-immunoprecipitation with anti-HA and anti-FLAG beads from tsA 201 cells co-expressing His6-P2X2, HA-P2X4, and FLAG-P2X6 confirmed interaction of all three subunits. AFM imaging with dual antibody decoration confirmed the P2X2/4/6 heterotrimer architecture. Sequential co-immunoprecipitation, atomic force microscopy imaging with antibody decoration FEBS letters High 24815693
2015 P2X6 subunit accumulates in the nucleus of hippocampal neurons in an age-dependent manner. Nuclear localization is facilitated by ER anchorage via the N-terminal domain, and the extracellular domain is required for nuclear entry. Inside the nucleus, P2X6 associates with spectrin α2 (nuclear envelope protein) and interacts with splicing factor 3A1, resulting in reduced mRNA splicing activity. Immunofluorescence, co-immunoprecipitation, in vivo nuclear fractionation, splicing activity assays PloS one Medium 25874565
2019 ATP-activated P2RX6 promotes renal cell carcinoma migration and invasion by mediating Ca2+ influx, which activates ERK1/2 phosphorylation and upregulates MMP9. METTL14-mediated m6A modification suppresses P2RX6 protein translation, thereby inhibiting this pro-invasive signaling axis. In vitro migration/invasion assays, Ca2+ influx measurement, Western blot for p-ERK1/2 and MMP9, m6A/METTL14 knockdown and overexpression, in vivo xenograft Journal of experimental & clinical cancer research Medium 31159832
2007 P2X6 receptor undergoes alternative splicing during mouse brain development and during in vitro neuronal differentiation. A full-length and an alternatively spliced form were detected; the spliced form predominates during neuronal differentiation of P19 cells, whereas the full-length form predominates during postnatal brain development, suggesting alternative splicing regulates P2X6 function. RT-PCR, in vitro differentiation model (P19 cells) Experimental physiology Low 17259301
1997 P2XM (the human P2X6 ortholog, also known as P2RX6) is a p53-inducible gene. Wild-type p53 induces P2XM expression; the gene contains functional p53-binding sites. It is expressed predominantly in skeletal muscle and maps to chromosome 22q11. p53-tagged genomic cloning, Northern blot, chromosomal mapping Cancer research Medium 9242461
2005 In cardiac fibroblasts, TNFα prevents ATP-induced downregulation of P2X6 mRNA (desensitization), suggesting TNFα interaction with P2X6 abrogates a protective mechanism against Ca2+ overload and cell death. ATP/BzATP via P2X6 induces apoptosis in cardiac fibroblasts and cardiomyocytes, which is exacerbated by TNFα. Primary cardiac fibroblast culture, apoptosis assays, real-time PCR, P2X6 mRNA quantification after agonist and TNFα treatment Journal of molecular and cellular cardiology Low 16242142

Source papers

Stage 0 corpus · 21 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1996 Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. The Journal of neuroscience : the official journal of the Society for Neuroscience 768 8786426
1998 Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. The Journal of neuroscience : the official journal of the Society for Neuroscience 204 9736638
2005 Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. The Journal of biological chemistry 156 15657042
2000 Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes. The Journal of neuroscience : the official journal of the Society for Neuroscience 105 10864944
2019 The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway. Journal of experimental & clinical cancer research : CR 99 31159832
1997 Cloning of P2XM, a novel human P2X receptor gene regulated by p53. Cancer research 73 9242461
2004 Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel alpha beta-methylene ATP-sensitive phenotype. Molecular pharmacology 61 15044628
2006 An uncharged region within the N terminus of the P2X6 receptor inhibits its assembly and exit from the endoplasmic reticulum. Molecular pharmacology 53 16452399
1999 Expression of two ATP-gated ion channels, P2X5 and P2X6, in developing chick skeletal muscle. Developmental dynamics : an official publication of the American Association of Anatomists 47 10633863
2002 P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cellular and molecular life sciences : CMLS 46 12088286
2005 P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death. Journal of molecular and cellular cardiology 45 16242142
2009 Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract. Histochemistry and cell biology 39 19946698
2007 Alternative splicing of P2X6 receptors in developing mouse brain and during in vitro neuronal differentiation. Experimental physiology 30 17259301
2001 Immunoreactivity to P2X(6) receptors in the rat hypothalamo-neurohypophysial system: an ultrastructural study with extravidin and colloidal gold-silver labelling. Neuroscience 27 11591462
2014 Identification of P2X2/P2X4/P2X6 heterotrimeric receptors using atomic force microscopy (AFM) imaging. FEBS letters 19 24815693
1999 Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours. British journal of cancer 13 10376970
2003 Expression of P2X6, a purinergic receptor subunit, is affected by dietary zinc deficiency in rat hippocampus. Biological trace element research 12 12713031
2015 Age-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1. PloS one 11 25874565
2016 P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis. PloS one 10 27254077
1998 Cloning and characterization of the murine P2XM receptor gene. Journal of human genetics 9 9852680
2024 Next Generation Sequencing and Electromyography Reveal the Involvement of the P2RX6 Gene in Myopathy. Current issues in molecular biology 5 38392191